A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis

Inclusion Criteria:

- Subjects must present with a clinical diagnosis of stable (at least 3 months)
plaque-type psoriasis.

- Subjects with psoriasis involving 10 to 20% BSA, not including the face, scalp,
groin, axillae and other intertriginous areas.

- Subjects must have an IGA grade of 3 (moderate) at the Baseline Visit

Exclusion Criteria:

- Current diagnosis of unstable forms of psoriasis including guttate, erythrodermic,
exfoliative or pustular psoriasis.

- Other inflammatory skin disease that may confound the evaluation of the plaque
psoriasis (e.g., atopic dermatitis, contact dermatitis, tinea corporis).

- Presence of pigmentation, extensive scarring, or pigmented lesions or sunburn which
could interfere with the rating of efficacy parameters.

- History of psoriasis unresponsive to topical treatments.

- History of organ transplant requiring immunosuppression, HIV, or other
immunocompromised state.